Warner-Lambert
Executive Summary
House Commerce Committee staff accompanied FDA on an inspection of a Parke-Davis finished-dose manufacturing facility in Ireland the week of June 29. Committee staff wanted first hand experience with FDA's foreign inspection program as part of an ongoing investigation ("The Pink Sheet" May 4, p. 12)